Continuous Glucose Monitoring Systems Market Size (USD 31.70 billion by 2031): Achieves Record-breaking Growth in Meeting Healthcare Requirements

Allied Market Research published a report, titled, "𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐁𝐲 𝐂𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭 (𝐒𝐞𝐧𝐬𝐨𝐫𝐬 , 𝐓𝐫𝐚𝐧𝐬𝐦𝐢𝐭𝐭𝐞𝐫𝐬 𝐚𝐧𝐝 𝐑𝐞𝐜𝐞𝐢𝐯𝐞𝐫𝐬 ), 𝐁𝐲 𝐃𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐲 (𝐂𝐡𝐢𝐥𝐝 𝐏𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧, 𝐀𝐝𝐮𝐥𝐭 𝐏𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧), 𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐬, 𝐇𝐨𝐦𝐞 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞, 𝐎𝐭𝐡𝐞𝐫𝐬): 𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭, 𝟐𝟎𝟐𝟏-𝟐𝟎𝟑𝟏." According to the report, the global continuous glucose monitoring systems industry was estimated at USD 6.62 billion in 2021 and is anticipated to hit USD 31.70 billion by 2031, registering a CAGR of 17% from 2022 to 2031.

The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐨𝐧 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐌𝐚𝐫𝐤𝐞𝐭-

• Increase in demand from healthcare workers for safer ways to monitor hospitalized diabetes patients with COVID-19 impacted the global continuous glucose monitoring systems market positively.
• FDA had encouraged manufacturers to supply continuous glucose monitoring (CGM) systems for use in the hospital setting during the global health crisis. This way, the frontline healthcare workers in hospitals were able to monitor diabetic patients remotely.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/1795

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Increase in prevalence of hematologic diseases, surge in number of accidents, and rise in geriatric population propel the growth of the global blood bank market.Asia-Pacific is expected to witness the highest CAGR of 6.4% from 2020 to 2027.Governments, hospitals, and blood banks have been appealing patients who recovered from Covid-19 to donate their plasma as it contains Covid-19 antibodies that help recovering patients to fight against the disease.

𝐓𝐨𝐩 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• DexCom Inc.
• Johnson & Johnson
• Novo Nordisk A/S
• F. Hoffman-La Roche Ltd
• Abbott Laboratories
• GlySens Incorporated
• Medtronic plc
• Ypsomed AG
• Senseonics
• Menarini Diagnostics S.R.L.

𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

By demography, the adult population segment accounted for more than 90% of the global continuous glucose monitoring systems market share in 2021, and is anticipated to rule the roost during the forecast period. The same segment would also portray the fastest CAGR of 17.1% throughout the forecast period. This is due to the rise in the prevalence of diabetics and increase in the geriatric population across the world.
By end-user, the hospital and clinics segment held the major share in 2019, garnering nearly half of the global continuous glucose monitoring systems market. The same segment would also portray the fastest CAGR of 17.4% from 2022 to 2031. This is owing to the rise in the number of continuous glucose monitoring systems in hospitals.

By component, the sensors segment accounted for nearly three-fifths of the global continuous glucose monitoring systems market share in 2021, and is expected to rule the roost by the end of 2031. The same segment would also cite the fastest CAGR of 17.2% throughout the forecast period. Advancements in technology in the development of continuous glucose monitoring systems fuel the segment's growth.

By region, North America garnered the highest share in 2021, contributing to nearly half of the global continuous glucose monitoring systems market revenue. This is attributed to the higher adoption of advanced CGMs, surge in the geriatric population suffering from diabetes, availability of well-developed healthcare infrastructure, and increase in the prevalence of type 2 diabetes across the world. Asia-Pacific, simultaneously, would showcase the fastest CAGR of 17.9% from 2022 to 2031. High prevalence of the diabetic population in India, improvement in healthcare awareness, and rise in R&D activities for developing innovative CGM systems fuel the growth of the market.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/1795

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.